A Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Frequency, and Prognosis in Non-small Cell Lung Cancer Patients Eligible for Curative Treatment.

Not yet recruitingOBSERVATIONAL

Enrollment

350

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2029

Conditions

NSCLC, Stage I, II, III

Trial Locations (1)

National Cancer Center Hospital, Chuo-ku